source
- Shionogi receives FDA nod for first oral COVID-19 post-exposure prevention pillShionogi announced that the U.S. Food and Drug Administration has granted approval for its oral antiviral designed to prevent COVID-19 after exposure. The product is indicated for adults and child…
- Medicare withholds cost data for senior GLP-1 obesity drugs as Massachusetts sues UnitedHealthMedicare announced that seniors can obtain Wegovy and Zepbound for $50 a month starting in July, but the agency has not disclosed how much the program will cost taxpayers. The absence of cost tran…